KPNA5 Suppresses Malignant Progression of Ovarian Cancer Through Importing the PTPN4 Into the Nucleus
Cancer Medicine · 2025
DOI: 10.1002/cam4.70731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Yanming Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Suzhou Cancer Center Core Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Suzhou, C…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, alpha Karyopherins, Cell Nucleus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou GuSu Health Talent Research Project.
Abstract (Originalsprache)
Background
Abnormal protein localization due to disrupted nucleoplasmic transport is common in tumor cells, but its mechanisms are not well understood. Nuclear pore complexes and nuclear transporter proteins are crucial for protein transport between the nucleus and cytoplasm. Evidence increasingly shows that abnormal expression of karyopherin family proteins disrupts protein translocation, affecting processes like cell differentiation, proliferation, apoptosis, and transcriptional regulation. However, their functions and roles in ovarian cancer remain unclear.
Methods
The expression level of KPNA5 in ovarian cancer tissues and cells was detected by IHC, Western blot, and qPCR. CCK‐8 and colony formation assays were used to assess cell proliferation ability. Transwell assay was conducted to determine cell migration and invasion capacity. A xenograft model was used to assess the effect of KPNA5 on tumor growth in vivo.
Results
KPNA5 expression is downregulated in ovarian cancer (OC) tissues. Low KPNA5 levels were associated with poor survival in OC patients, validated by an OC tissue sample cohort. Overexpression of KPNA5 significantly suppressed OC cell proliferation, tumor growth, and invasion in both in vitro and in vivo studies. Mechanistically, KPNA5 recognizes nuclear localization signals (NLSs) in PTPN4, mediating its nuclear transport and inhibiting STAT3 phosphorylation and its downstream signaling pathway. Similarly, PTPN4 overexpression reduced OC cell viability and invasion, also suppressing STAT3 phosphorylation.
Conclusions
Our findings identify KPNA5 as a tumor suppressor in OC, presenting a potential therapeutic target for OC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Suzhou Cancer Center Core Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Suzhou, China.
- Department of Oncology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, China.
- Department of Obstetrics and Gynecology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Suzhou, China.
- Department of Oncology, Huaian Hospital of Huaian City, Huaian, Jiangsu, China.
- Department of Computer Science and Engineering, University of California, Davis, California, USA.
- Department of Obstetrics and Gynecology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
ORCID-Profile: Kun Zhao, Xiaoqing Li, Ming Sun
Förderung
- Suzhou GuSu Health Talent Research Project
Zitieren
APA
Hu, Y., Zhou, J., Ling, X., Zhao, K., Huang, P., Gao, M., Li, X., Sun, M., Zou, Y., & Feng, G. (2025). KPNA5 Suppresses Malignant Progression of Ovarian Cancer Through Importing the PTPN4 Into the Nucleus. Cancer Medicine. https://doi.org/10.1002/cam4.70731
Vancouver
Hu Y, Zhou J, Ling X, Zhao K, Huang P, Gao M, et al. KPNA5 Suppresses Malignant Progression of Ovarian Cancer Through Importing the PTPN4 Into the Nucleus. Cancer Medicine. 2025. doi:10.1002/cam4.70731
BibTeX
@article{Hu2025,
author = {Hu, Yanming and Zhou, Jing and Ling, Xinru and Zhao, Kun and Huang, Peng and Gao, Max and Li, Xiaoqing and Sun, Ming and Zou, Yanfen and Feng, Guannan},
title = {KPNA5 Suppresses Malignant Progression of Ovarian Cancer Through Importing the PTPN4 Into the Nucleus},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70731}
}
EUVIMED